The history of Sildenafil presents a challenging picture for shareholders. While the initial launch generated significant returns, the lapse of its intellectual property protection opened the avenue to cheaper https://bookmarkquotes.com/story21773229/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity